Jane Street
BNGO icon

Jane Street’s Bionano Genomics BNGO Stock Holding History

Jane Street’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-59
Closed -$21.5K – 8651
2023
Q2 		$21.5K Sell
59
-52
-47% -$23.5K ﹤0.01% 8354
2023
Q1 		$73.8K Sell
111
-181
-62% -$161K ﹤0.01% 8343
2022
Q4 		$256K Sell
292
-115
-28% -$145K ﹤0.01% 7285
2022
Q3 		$446K Buy
407
+109
+37% +$144K ﹤0.01% 6889
2022
Q2 		$247K Buy
298
+77
+35% +$79.2K ﹤0.01% 7895
2022
Q1 		$342K Sell
221
-1,713
-89% -$2.31M ﹤0.01% 8184
2021
Q4 		$3.47M Sell
1,934
-153
-7% -$409K ﹤0.01% 3445
2021
Q3 		$6.89M Sell
2,087
-257
-11% -$899K ﹤0.01% 2291
2021
Q2 		$10.3M Buy
2,344
+882
+60% +$3.48M ﹤0.01% 1668
2021
Q1 		$7.09M Buy
+1,462
New +$8.24M ﹤0.01% 1941

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street's BNGO Position: Q1 2026 in Review

Jane Street sold out of Bionano Genomics (BNGO) in Q1 2026, closing a stake of 22,170 shares — an estimated $33.9K sold.

Jane Street first reported a position in BNGO in Q4 2020 and held it in 16 quarters. The position peaked at $9.8M in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Jane Street reported no remaining Bionano Genomics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 22,170 Bionano Genomics shares in Q1 2026, an estimated $33.9K.
  • Jane Street first reported a position in Bionano Genomics in Q4 2020 and held it in 16 quarters.
  • Jane Street's Bionano Genomics position peaked at $9.8M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.